Cargando…
Melatonin: A Molecule for Reducing Breast Cancer Risk
The objective of this article is to review the basis supporting the usefulness of melatonin as an adjuvant therapy for breast cancer (BC) prevention in several groups of individuals at high risk for this disease. Melatonin, as a result of its antiestrogenic and antioxidant properties, as well as its...
Autores principales: | González-González, Alicia, Mediavilla, María Dolores, Sánchez-Barceló, Emilio J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017232/ https://www.ncbi.nlm.nih.gov/pubmed/29415446 http://dx.doi.org/10.3390/molecules23020336 |
Ejemplares similares
-
Clinical Uses of Melatonin in Pediatrics
por: Sánchez-Barceló, Emilio J., et al.
Publicado: (2011) -
Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells
por: Martínez-Campa, C, et al.
Publicado: (2009) -
Inhibitory effects of pharmacological doses of melatonin on aromatase activity and expression in rat glioma cells
por: González, A, et al.
Publicado: (2007) -
Significance of High Levels of Endogenous Melatonin in Mammalian Cerebrospinal Fluid and in the Central Nervous System
por: Tan, Dun-Xian, et al.
Publicado: (2010) -
Scientific Basis for the Potential Use of Melatonin in Bone Diseases: Osteoporosis and Adolescent Idiopathic Scoliosis
por: Sánchez-Barceló, E. J., et al.
Publicado: (2010)